BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8686424)

  • 1. Comparison of measurement between Xe/CT CBF and PET in cerebrovascular disease and brain tumor.
    Nariai T
    Acta Neurol Scand Suppl; 1996; 166():10-2. PubMed ID: 8686424
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between cerebral blood flow values obtained by Xenon/CT and Kety-Schmidt (N2O) methods.
    Tone O; Ito U; Tomita H; Akimoto H; Sakemi H
    Acta Neurol Scand Suppl; 1996; 166():18-21. PubMed ID: 8686435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronal flow mapping with Xe/helical CT.
    Nakano S; Kitahara T
    Acta Neurol Scand Suppl; 1996; 166():32-5. PubMed ID: 8686439
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status and controversies in the inhalation protocols for the Xenon CT CBF method.
    Kashiwagi S; Nagamitsu T; Yamashita T
    Acta Neurol Scand Suppl; 1996; 166():51-3. PubMed ID: 8686442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by xenon 133 single-photon emission CT.
    Leinsinger G; Piepgras A; Einhäupl K; Schmiedek P; Kirsch CM
    AJNR Am J Neuroradiol; 1994 Aug; 15(7):1327-32. PubMed ID: 7976945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography.
    Nariai T; Suzuki R; Hirakawa K; Maehara T; Ishii K; Senda M
    AJNR Am J Neuroradiol; 1995 Mar; 16(3):563-70. PubMed ID: 7793382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of rCBF in skull base lesions.
    Mirzai S; Samii M
    Acta Neurol Scand Suppl; 1996; 166():155-60. PubMed ID: 8686434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cerebral blood flow between perfusion computed tomography and xenon-enhanced computed tomography for normal subjects: territorial analysis.
    Sase S; Honda M; Machida K; Seiki Y
    J Comput Assist Tomogr; 2005; 29(2):270-7. PubMed ID: 15772551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xe/CT CBF measurements during migraine and cluster headache.
    Kobari M
    Acta Neurol Scand Suppl; 1996; 166():150-1. PubMed ID: 8686433
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cerebral blood flow data obtained by computed tomography (CT) perfusion with that obtained by xenon CT using 320-row CT.
    Takahashi S; Tanizaki Y; Kimura H; Akaji K; Kano T; Suzuki K; Takayama Y; Kanzawa T; Shidoh S; Nakazawa M; Yoshida K; Mihara B
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):635-41. PubMed ID: 25561317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional cerebral blood flow measured with xenon-133 inhalation using emission tomography.
    Lassen NA
    Rev Electroencephalogr Neurophysiol Clin; 1980; 10(4):407-11. PubMed ID: 6975490
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regional cerebral blood flow in the acute stage with ischemic cerebrovascular disease studied by xenon-133 inhalation and single photon emission computerized tomography].
    Kurokawa H; Iino K; Kojima H; Saito H; Suzuki M; Watanabe K; Kato T
    No To Shinkei; 1987 May; 39(5):437-46. PubMed ID: 3497656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and removal of arteriovenous malformation: Impact of regional cerebral blood flow, as assessed with xenon/CT.
    Van Roost D; Schramm J; Solymosi L; Hartmann A
    Acta Neurol Scand Suppl; 1996; 166():136-8. PubMed ID: 8686430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of changes in cerebral blood flow and cerebral oxygen saturation measured by near infrared spectroscopy (NIRS) after acetazolamide.
    Holzschuh M; Woertgen C; Metz C; Brawanski A
    Acta Neurochir (Wien); 1997; 139(1):58-62. PubMed ID: 9059713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of xenon-enhanced computed tomography-defined cerebral blood flow reactivity and collateral flow patterns.
    Smith HA; Thompson-Dobkin J; Yonas H; Flint E
    Stroke; 1994 Sep; 25(9):1784-7. PubMed ID: 8073458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamics of hypertensive putaminal hemorrhage evaluated by Xenon-enhanced computed tomography and acetazolamide test.
    Kitahara T; Yamashita T; Kashiwagi S; Kawakami N; Ishihara H; Ito H
    Acta Neurol Scand Suppl; 1996; 166():139-43. PubMed ID: 8686431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow alteration by acetazolamide during carotid balloon occlusion: parameters reflecting cerebral perfusion pressure in the acetazolamide test.
    Okudaira Y; Arai H; Sato K
    Stroke; 1996 Apr; 27(4):617-21. PubMed ID: 8614917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of regional cerebral blood flow (rCBF) in cerebrovascular disease using SPECT and N-isopropyl-p-[123I] iodoamphetamine (IMP): comparison with IMP hemispheric uptake count and mean CBF by 133Xe arterial infusion method].
    Seto H; Futatsuya R; Kamei T; Taki K; Kakishita M; Moto A; Endo T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1135-41. PubMed ID: 3879348
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced ct cerebral blood flow and transcranial Doppler.
    Pindzola RR; Balzer JR; Nemoto EM; Goldstein S; Yonas H
    Stroke; 2001 Aug; 32(8):1811-7. PubMed ID: 11486110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of therapeutic indications using positron emission tomography (PET)--cerebrovascular diseases and brain tumor].
    Higano S; Uemura K; Shishido F
    No To Shinkei; 1988 May; 40(5):439-49. PubMed ID: 3261987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.